Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)
- Status
- COMPLETED
- Phase
- PHASE2
Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
- Status
- COMPLETED
- Phase
- PHASE1
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2